(Total Views: 461)
Posted On: 12/10/2020 9:31:59 AM
Post# of 153941
“Seems like many biotech release interim data numbers, but not Cytodyn?????”
CYDY has historically not planned trials very well and this is likely why a release of the interim data was not part of the trial protocol. Regardless, I believe it’s time that NP unblind the data at 75% and seek EUA if the DSMC doesn’t make that recommendation (seems likely they will).
CYDY has historically not planned trials very well and this is likely why a release of the interim data was not part of the trial protocol. Regardless, I believe it’s time that NP unblind the data at 75% and seek EUA if the DSMC doesn’t make that recommendation (seems likely they will).
(0)
(0)
